Neuren Pharmaceuticals | NEU - Assets

Stock Price
13.14
Daily Change
0.84 6.83%
Monthly
12.50%
Yearly
50.69%
Q2 Forecast
11.77

Neuren Pharmaceuticals reported AUD342.86M in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Clinuvel Pharmaceuticals AUD 269.7M 2.05M Dec/2025
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Genetic Signatures AUD 49.04M 5.59M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
Medical Developments International AUD 63.57M 2.83M Dec/2025
Neuren Pharmaceuticals AUD 342.86M 11.61M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Paradigm Biopharmaceuticals AUD 23.15M 1.42M Dec/2025
PYC Therapeutics AUD 159.13M 24.15M Dec/2025
Starpharma Holdings AUD 26.17M 746K Dec/2025
Tectonic Therapeutic USD 261.04M 15.96M Dec/2025
Telix Pharmaceuticals AUD 1.16B 25.97M Dec/2025
Viatris USD 37.19B 727.3M Dec/2025
Xeris Pharmaceuticals USD 383.53M 13.34M Dec/2025